Rapid Rx Quiz: Severe Asthma Treatment

Mary L. Windle, PharmD


June 16, 2023

Nearly 400 million people globally have asthma, a chronic inflammatory disorder. This common airway issue is characterized by chest tightness, coughing, shortness of breath, tissue remodeling, variable limitation of airflow, and wheezing. In as many as 10% of these patients, asthma is severe and uncontrolled, despite maintaining maximal optimal therapy. Severe asthma is a heterogeneous condition made up of eosinophilic asthma and other phenotypes; however, all patients with severe asthma experience a range of symptoms and medication adverse effects. Early diagnosis and effective management are critical to improve outcomes and quality of life.

Are you up-to-date on the latest research on severe asthma treatment, including effective biologics, human monoclonal antibody benefits, and factors associated with higher asthma biologic adherence? Test yourself with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.